← Back to screener

Edwards Lifesciences Corp EW

Rank #989 · NYSE · $53.0B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
55.1
P/E
37.8
P/B
5.30
ROE
14.0%
Op. Margin
26.1%
Debt Ratio
30%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 37.8x, P/B 5.30x. Ranks in the top 56% of the universe.

Profitability ★★★★☆
Good

ROE 14.0%. Ranks in the top 23% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 30%. Ranks in the top 17% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Good

Revenue growth of 12.2% year over year. Ranks in the top 30% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–––$0.9B–101
2012–––$1.2B–71
2013–––$1.3B–70
2014–––$1.3B–104
2015–––$1.5B–140
2016–––$1.5B–163
2017–––$2.2B–106
2018$3.0B$0.8B–$2.5B25.3126
2019$3.4B$1.1B–$2.6B31.7103
2020$3.7B$0.7B–$3.0B20.1119
2021$4.3B$1.1B–$3.1B26.485
2022$4.4B$0.9B–$4.1B20.564
2023$5.2B$1.7B$1.5B$5.8B32.343
2024$4.5B$1.5B$1.5B$6.7B33.640
2025$5.0B$1.3B$1.4B$10.0B26.130

← See the full screener